Life Sciences
Mouse Scroll Icon
October 2020

Vaccitech Appoints Two Executives

Vaccitech Limited has announced the following executive appointments:

  • Georgy Egorov has been named the company’s Chief Financial Officer. Georgy was most recently Chief Financial Officer and Board Member for Exscientia. Earlier in his career, he also spent time within the Goldman Sachs and UBS investment banking groups.
  • Dr. Margaret (Meg) Marshall has officially been named Chief Medical Officer after serving in a consultant capacity for the company since June. Previously, Meg was a Director in Clinical Research for Kyowa Kirin, Kite Pharma and Pfizer.

Vaccitech is a clinical stage T cell immunotherapy and vaccine company developing products to treat and prevent infectious disease and cancer. The Oxford-based company is a spinout from the University of Oxford’s Jenner Institute.